214 related articles for article (PubMed ID: 22370640)
1. MTBP suppresses cell migration and filopodia formation by inhibiting ACTN4.
Agarwal N; Adhikari AS; Iyer SV; Hekmatdoost K; Welch DR; Iwakuma T
Oncogene; 2013 Jan; 32(4):462-70. PubMed ID: 22370640
[TBL] [Abstract][Full Text] [Related]
2. MDM2 binding protein, a novel metastasis suppressor.
Iwakuma T; Agarwal N
Cancer Metastasis Rev; 2012 Dec; 31(3-4):633-40. PubMed ID: 22684342
[TBL] [Abstract][Full Text] [Related]
3. MTBP inhibits migration and metastasis of hepatocellular carcinoma.
Bi Q; Ranjan A; Fan R; Agarwal N; Welch DR; Weinman SA; Ding J; Iwakuma T
Clin Exp Metastasis; 2015 Apr; 32(4):301-11. PubMed ID: 25759210
[TBL] [Abstract][Full Text] [Related]
4. Mtbp haploinsufficiency in mice increases tumor metastasis.
Iwakuma T; Tochigi Y; Van Pelt CS; Caldwell LC; Terzian T; Parant JM; Chau GP; Koch JG; Eischen CM; Lozano G
Oncogene; 2008 Mar; 27(13):1813-20. PubMed ID: 17906694
[TBL] [Abstract][Full Text] [Related]
5. Long Non-Coding RNA CRYBG3 Promotes Lung Cancer Metastasis via Activating the eEF1A1/MDM2/MTBP Axis.
Wu A; Tang J; Guo Z; Dai Y; Nie J; Hu W; Liu N; Ye C; Li S; Pei H; Zhou G
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809929
[TBL] [Abstract][Full Text] [Related]
6. MTBP regulates cell survival and therapeutic sensitivity in TP53 wildtype glioblastomas.
Song Y; Zhang L; Jiang Y; Hu T; Zhang D; Qiao Q; Wang R; Wang M; Han S
Theranostics; 2019; 9(20):6019-6030. PubMed ID: 31534534
[No Abstract] [Full Text] [Related]
7. Loss of MTBP expression is associated with reduced survival in a biomarker-defined subset of patients with squamous cell carcinoma of the head and neck.
Vlatković N; El-Fert A; Devling T; Ray-Sinha A; Gore DM; Rubbi CP; Dodson A; Jones AS; Helliwell TR; Jones TM; Boyd MT
Cancer; 2011 Jul; 117(13):2939-50. PubMed ID: 21692053
[TBL] [Abstract][Full Text] [Related]
8. A deficiency in Mdm2 binding protein inhibits Myc-induced B-cell proliferation and lymphomagenesis.
Odvody J; Vincent T; Arrate MP; Grieb B; Wang S; Garriga J; Lozano G; Iwakuma T; Haines DS; Eischen CM
Oncogene; 2010 Jun; 29(22):3287-96. PubMed ID: 20305689
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of alpha-actinin 4 upon epidermal growth factor exposure regulates its interaction with actin.
Shao H; Wu C; Wells A
J Biol Chem; 2010 Jan; 285(4):2591-600. PubMed ID: 19920151
[TBL] [Abstract][Full Text] [Related]
10. Regulation of p53 and MDM2 activity by MTBP.
Brady M; Vlatkovic N; Boyd MT
Mol Cell Biol; 2005 Jan; 25(2):545-53. PubMed ID: 15632057
[TBL] [Abstract][Full Text] [Related]
11. MTBP Promotes the Invasion and Metastasis of Hepatocellular Carcinoma by Enhancing the MDM2-Mediated Degradation of E-Cadherin.
Lu S; Zhou W; Wei H; He L; Li L
Dig Dis Sci; 2015 Dec; 60(12):3681-90. PubMed ID: 26280083
[TBL] [Abstract][Full Text] [Related]
12. ACTN4 Promotes the Proliferation, Migration, Metastasis of Osteosarcoma and Enhances its Invasive Ability through the NF-κB Pathway.
Huang Q; Li X; Huang Z; Yu F; Wang X; Wang S; He Z; Lin J
Pathol Oncol Res; 2020 Apr; 26(2):893-904. PubMed ID: 30879239
[TBL] [Abstract][Full Text] [Related]
13. α-Actinin 4 potentiates nuclear factor κ-light-chain-enhancer of activated B-cell (NF-κB) activity in podocytes independent of its cytoplasmic actin binding function.
Zhao X; Hsu KS; Lim JH; Bruggeman LA; Kao HY
J Biol Chem; 2015 Jan; 290(1):338-49. PubMed ID: 25411248
[TBL] [Abstract][Full Text] [Related]
14. Long non‑coding RNA PCAT6 promotes the development of osteosarcoma by increasing MDM2 expression.
Guan X; Xu Y; Zheng J
Oncol Rep; 2020 Dec; 44(6):2465-2474. PubMed ID: 33125146
[TBL] [Abstract][Full Text] [Related]
15. Regulation of p53 nuclear export through sequential changes in conformation and ubiquitination.
Nie L; Sasaki M; Maki CG
J Biol Chem; 2007 May; 282(19):14616-25. PubMed ID: 17371868
[TBL] [Abstract][Full Text] [Related]
16. [Novel splicing isoform of actin-binding protein alpha-actinin 4 in epidermoid carcinoma cells A431].
Aksenova VIu; Khotin MG; Turoverova LV; Iudintseva NM; Magnusson KÉ; Pinaev GP; Tentler DG
Tsitologiia; 2012; 54(1):25-32. PubMed ID: 22567897
[TBL] [Abstract][Full Text] [Related]
17. MDM2 binding induces a conformational change in p53 that is opposed by heat-shock protein 90 and precedes p53 proteasomal degradation.
Sasaki M; Nie L; Maki CG
J Biol Chem; 2007 May; 282(19):14626-34. PubMed ID: 17363365
[TBL] [Abstract][Full Text] [Related]
18. α-Actinin-4 enhances colorectal cancer cell invasion by suppressing focal adhesion maturation.
Fukumoto M; Kurisu S; Yamada T; Takenawa T
PLoS One; 2015; 10(4):e0120616. PubMed ID: 25860875
[TBL] [Abstract][Full Text] [Related]
19. ZCCHC10 suppresses lung cancer progression and cisplatin resistance by attenuating MDM2-mediated p53 ubiquitination and degradation.
Ning Y; Hui N; Qing B; Zhuo Y; Sun W; Du Y; Liu S; Liu K; Zhou J
Cell Death Dis; 2019 May; 10(6):414. PubMed ID: 31138778
[TBL] [Abstract][Full Text] [Related]
20. Tyro3-mediated phosphorylation of ACTN4 at tyrosines is FAK-dependent and decreases susceptibility to cleavage by m-Calpain.
Shao H; Wang A; Lauffenburger D; Wells A
Int J Biochem Cell Biol; 2018 Feb; 95():73-84. PubMed ID: 29274473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
